Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Falconi

Showing results (331-340 of 639) with videos related to

Pageof 64
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 17, 2023
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapyMarina Macchini, Giulio Belfiori, Stefano Crippa, et al.
Scientific Reports|December 11, 2019
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumorsMauro Cives, Stefano Partelli, Raffaele Palmirotta, et al.
Annals of Surgical Oncology|January 24, 2022
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-MakingGiovanni Marchegiani, Stefano Crippa, Giampaolo Perri, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 1, 2006
Intraductal papillary mucinous neoplasms and chronic pancreatitisGiorgio Talamini, Giuseppe Zamboni, Roberto Salvia, et al.
The American Journal of Gastroenterology|March 1, 2017
Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative ManagementStefano Crippa, Raffaele Pezzilli, Massimiliano Bissolati, et al.
Endocrine|July 10, 2025
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysisClaudio Ricci, Stefano Partelli, Davide Campana, et al.
Surgery|August 27, 2024
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrenceDomenico Tamburrino, Claudia Arcangeli, Federico De Stefano, et al.
Chirurgia Italiana|March 5, 2003
[Integrated project for the translational research on pancreatic ductal carcinoma]Stefano Marcucci, Antonio Bonora, Massimo Falconi, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 17, 2024
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosisMonica Consolandi, Mara Floris, Nicolò Pecorelli, et al.
Surgery|June 6, 2022
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fireFrancesca Aleotti, Stefano Crippa, Giulio Belfiori, et al.
Pageof 64

Showing results (331-340 of 639) with videos related to

Sort By:
Pageof 64
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 17, 2023
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapyMarina Macchini, Giulio Belfiori, Stefano Crippa, et al.
Scientific Reports|December 11, 2019
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumorsMauro Cives, Stefano Partelli, Raffaele Palmirotta, et al.
Annals of Surgical Oncology|January 24, 2022
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-MakingGiovanni Marchegiani, Stefano Crippa, Giampaolo Perri, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 1, 2006
Intraductal papillary mucinous neoplasms and chronic pancreatitisGiorgio Talamini, Giuseppe Zamboni, Roberto Salvia, et al.
The American Journal of Gastroenterology|March 1, 2017
Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative ManagementStefano Crippa, Raffaele Pezzilli, Massimiliano Bissolati, et al.
Endocrine|July 10, 2025
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysisClaudio Ricci, Stefano Partelli, Davide Campana, et al.
Surgery|August 27, 2024
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrenceDomenico Tamburrino, Claudia Arcangeli, Federico De Stefano, et al.
Chirurgia Italiana|March 5, 2003
[Integrated project for the translational research on pancreatic ductal carcinoma]Stefano Marcucci, Antonio Bonora, Massimo Falconi, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 17, 2024
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosisMonica Consolandi, Mara Floris, Nicolò Pecorelli, et al.
Surgery|June 6, 2022
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fireFrancesca Aleotti, Stefano Crippa, Giulio Belfiori, et al.
Pageof 64